These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 11345234)

  • 1. Effects of alprostadil on blood rheology and nucleoside metabolism in patients affected with lower limb chronic ischaemia.
    Acciavatti A; Laghi Pasini F; Capecchi PL; Messa GL; Lazzerini PE; De Giorgi L; Acampa M; Di Perri T
    Clin Hemorheol Microcirc; 2001; 24(1):49-57. PubMed ID: 11345234
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of a 4-week treatment with prostaglandin E1 on plasma endothelin-1 release in patients with intermittent claudication.
    Mangiafico RA; Malatino LS; Santonocito M; Messina R; Attinà T; Dell'Arte S; Sarnataro F
    Int J Clin Pharmacol Ther; 1999 Jul; 37(7):347-51. PubMed ID: 10442509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Microcirculation in peripheral arterial occlusive diseases will improve. Prostaglandin can prevent surgery].
    MMW Fortschr Med; 2003 Dec; 145(51-52):41. PubMed ID: 14974333
    [No Abstract]   [Full Text] [Related]  

  • 4. [Analysis of costs and results of prostaglandin (PGE1 alpha-cyclodestrin) therapy of peripheral arterial diseases].
    Bucci M; Iacobitti P; Laurora G; Cesarone MR
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):9-15. PubMed ID: 10658439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence of iloprost on blood rheology and tissue perfusion in patients with intermittent claudication.
    Ciuffetti G; Sokola E; Lombardini R; Pasqualini L; Pirro M; Mannarino E
    Kardiol Pol; 2003 Sep; 59(9):197-204. PubMed ID: 14618196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous prostaglandin E1 reduces monocyte chemoattractant protein-1 levels in peripheral arterial obstructive disease.
    Matsui K; Ikeda U; Murakami Y; Yoshioka T; Shimada K
    Am Heart J; 2003 Feb; 145(2):330-3. PubMed ID: 12595852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of thrombinic activation indexes, in patients with lower limb critic ischaemia, before and after prostaglandin E1 therapy.
    Trifiletti A; Bartolone S; Scamardi R; Pizzoleo MA; Attinà A; Sottilotta G; Canobbio V; Soraci S; Barbera N
    Minerva Cardioangiol; 1999 Mar; 47(3):55-8. PubMed ID: 10389444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Global analysis of data from studies with PDE1 alpha-cyslodextrin].
    Laurora G; Belcaro G; Cesarone MR; Incandela L; De Sanctis MT; Dugall M
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):65-8. PubMed ID: 10658448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Preoperative care of microcirculatory vessels in patients with lower limb arteriosclerosis obliterans].
    Kuznetsov MR; Koshkin VM; Karalkin AV; Boldin BV; Rodionov SV; Sergeeva NA; Petukhov EB; Golosnitskiĭ PIu
    Angiol Sosud Khir; 2005; 11(1):19-24. PubMed ID: 16034319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of severe intermittent claudication: ORACLE-PGE1 short term study. A randomised 40-week study. Evaluation of efficacy and costs].
    Cesarone MR; Belcaro G; Nicolaides AN; Griffin M; Geroulakos G; Ramaswami G; Cazaubon M; Barsotti A; Vasdekis S; Christopoulos D; Agus G; Bavera P; Mondani P; Ippolito E; Flenda F
    Minerva Cardioangiol; 2002 Dec; 50(6):683-90. PubMed ID: 12473989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of arm-ergometry versus treadmill exercise training to improve walking distance in patients with claudication.
    Treat-Jacobson D; Bronas UG; Leon AS
    Vasc Med; 2009 Aug; 14(3):203-13. PubMed ID: 19651669
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Circadian variations of cutaneous blood flow in normal subjects and in patients with peripheral arteriopathies. Effect of PGE1 and alpha-cyclodextrin].
    Laurora G; Belcaro G
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):45-9. PubMed ID: 10658444
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ["Responders and non-responders" to PGE1 and alpha-cyclodextrin].
    De Sanctis MT; Incandela L; Iacobitti P
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):31-6. PubMed ID: 10658442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravenous prostaglandin E1 reduces soluble vascular cell adhesion molecule-1 in peripheral arterial obstructive disease.
    Gianetti J; De Caterina M; De Cristofaro T; Ungaro B; Guercio RD; De Caterina R
    Am Heart J; 2001 Oct; 142(4):733-9. PubMed ID: 11579367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of low-density lipoprotein apheresis on patients with peripheral arterial disease. Peripheral Arterial Disease LDL Apheresis Multicenter Study (P-LAS).
    Tsuchida H; Shigematsu H; Ishimaru S; Iwai T; Akaba N; Umezu S
    Int Angiol; 2006 Sep; 25(3):287-92. PubMed ID: 16878078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of controlled vascular training on the pain free walking distance and plasmaviscosity in patients suffering from peripheral arterial occlusive disease.
    Häfner HM; Jünger I; Geyer A; Jünger M; Strölin A
    Clin Hemorheol Microcirc; 2009; 41(1):73-80. PubMed ID: 19136745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Intra-arterial infusion of PGE1 alpha cyclodextrin].
    Laurora G; Cesarone MR; Belcaro G; Incandela L; De Sanctis MT; Fascetti E; D'Archivio C
    Minerva Cardioangiol; 1998 Oct; 46(10 Suppl 1):17-20. PubMed ID: 10658440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alprostadil: modes of actions in peripheral arterial occlusive disease.
    Karetova D; Bultas J; Vondracek V; Aschermann M
    Am J Ther; 1997; 4(11-12):359-63. PubMed ID: 10423631
    [No Abstract]   [Full Text] [Related]  

  • 20. Short term treatment with prostanoids in critical limb ischaemia: three months follow-up.
    Martini R; Camporese G; Salmistraro G; Scomparin MA; Verlato F; Andreozzi GM
    Minerva Cardioangiol; 1999 Dec; 47(12):656-7. PubMed ID: 10670248
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.